PL4274572T3 - Nowe inhibitory autotaksyny - Google Patents
Nowe inhibitory autotaksynyInfo
- Publication number
- PL4274572T3 PL4274572T3 PL21917385.3T PL21917385T PL4274572T3 PL 4274572 T3 PL4274572 T3 PL 4274572T3 PL 21917385 T PL21917385 T PL 21917385T PL 4274572 T3 PL4274572 T3 PL 4274572T3
- Authority
- PL
- Poland
- Prior art keywords
- autotaxin
- novel inhibitors
- inhibitors
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202121000352 | 2021-01-05 | ||
| PCT/IB2021/060738 WO2022149010A1 (en) | 2021-01-05 | 2021-11-19 | Novel inhibitors of autotaxin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4274572T3 true PL4274572T3 (pl) | 2026-04-27 |
Family
ID=82358085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21917385.3T PL4274572T3 (pl) | 2021-01-05 | 2021-11-19 | Nowe inhibitory autotaksyny |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240327407A1 (pl) |
| EP (2) | EP4599849A3 (pl) |
| JP (1) | JP2024502337A (pl) |
| KR (1) | KR20230128511A (pl) |
| CN (1) | CN116806150A (pl) |
| DK (1) | DK4274572T3 (pl) |
| FI (1) | FI4274572T3 (pl) |
| HR (1) | HRP20260363T1 (pl) |
| PL (1) | PL4274572T3 (pl) |
| PT (1) | PT4274572T (pl) |
| TW (1) | TW202235078A (pl) |
| WO (1) | WO2022149010A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202502735A (zh) * | 2023-03-02 | 2025-01-16 | 印度商吉德斯生命科學有限公司 | 新穎atx抑制劑 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241029B (it) * | 1990-12-11 | 1993-12-27 | Rotta Research Lab | Derivati amidici biciclici e policiclici degli acidi glutammico, aspartico e 2-ammino adipico ad attivita' antigastrinica e procedimento per la loro preparazione |
| GB9200420D0 (en) * | 1992-01-09 | 1992-02-26 | James Black Foundation The Lim | Amino acid derivatives |
| IT1263116B (it) * | 1992-04-09 | 1996-07-30 | Rotta Research Lab | Derivati basici dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso farmaceutico |
| WO2003007888A2 (en) * | 2001-07-20 | 2003-01-30 | Adipogenix, Inc. | Fat accumulation-modulating compounds |
| WO2006006490A1 (ja) * | 2004-07-08 | 2006-01-19 | Ono Pharmaceutical Co., Ltd. | スピロ化合物 |
| UY34094A (es) * | 2011-05-27 | 2013-01-03 | Novartis Ag | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina |
| CN104364239B (zh) * | 2012-06-13 | 2017-08-25 | 霍夫曼-拉罗奇有限公司 | 二氮杂螺环烷烃和氮杂螺环烷烃 |
| MX368615B (es) | 2012-09-25 | 2019-10-09 | Hoffmann La Roche | Derivados bicíclicos como inhibidores de la autotaxina (atx) que son inhibidores de la producción de ácido lisofosfatídico (lpa) y el uso de los mismos. |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| RU2675818C2 (ru) | 2013-03-14 | 2018-12-25 | Галапаго Нв | Новые соединения и фармацевтические композиции, их содержащие, для лечения воспалительных расстройств |
| EP3010922B1 (en) | 2013-06-19 | 2017-03-15 | Galapagos NV | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| EP3046909A4 (en) | 2013-09-17 | 2017-03-29 | Pharmakea, Inc. | Heterocyclic vinyl autotaxin inhibitor compounds |
| CA2937616A1 (en) | 2014-03-26 | 2015-10-01 | F. Hoffmann-La Roche Ag | Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
| CU24442B1 (es) * | 2014-04-04 | 2019-09-04 | X Rx Inc | Derivados de n-(1-(espirocíclico)oxo) amida sustituidos como inhibidores de autotaxina |
| BR112016024473A2 (pt) | 2014-04-23 | 2018-01-23 | X Rx Inc | composto, composição farmacêutica, e, método para tratamento de uma doença e/ou condição |
| WO2017050732A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
| AU2016328436B2 (en) | 2015-09-24 | 2020-05-14 | F. Hoffmann-La Roche Ag | New bicyclic compounds as dual ATX/CA inhibitors |
| BR112017026682A2 (pt) | 2015-09-24 | 2018-08-14 | Hoffmann La Roche | novos compostos bicíclicos como inibidores de dupla ação de atx/ca |
| JP6876685B2 (ja) | 2015-09-24 | 2021-05-26 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ａｔｘ阻害剤としての二環式化合物 |
| GB201519195D0 (en) * | 2015-10-30 | 2015-12-16 | Heptares Therapeutics Ltd | CGRP Receptor Antagonists |
| AU2017228371A1 (en) * | 2016-03-04 | 2018-09-13 | Gilead Sciences, Inc. | Compositions and combinations of autotaxin inhibitors |
| US11407677B2 (en) | 2016-07-19 | 2022-08-09 | Agc Glass Europe | Glass for autonomous car |
| CN109384803B (zh) | 2017-08-09 | 2021-08-31 | 广州市恒诺康医药科技有限公司 | Atx抑制剂及其制备方法和应用 |
| TW201938517A (zh) | 2017-12-01 | 2019-10-01 | 景凱生物科技股份有限公司 | 苯並雜環化合物及其用途 |
| CN111620865B (zh) | 2018-02-14 | 2021-06-11 | 苏州信诺维医药科技股份有限公司 | 一种杂环化合物、其应用及含其的药物组合物 |
| CA3108809C (en) | 2018-05-24 | 2023-08-29 | Guangzhou Henovcom Bioscience Co., Ltd. | Heteroaromatic compounds, pharmaceutical compositions and uses thereof |
| WO2019228403A1 (en) | 2018-05-29 | 2019-12-05 | Fronthera U.S. Pharmaceuticals Llc | Autotaxin inhibitors and uses thereof |
| WO2021247893A1 (en) * | 2020-06-03 | 2021-12-09 | Yumanity Therapeutics, Inc. | Bicyclic heteroaromatic amide compounds and uses thereof |
-
2021
- 2021-11-19 JP JP2023540691A patent/JP2024502337A/ja active Pending
- 2021-11-19 PT PT219173853T patent/PT4274572T/pt unknown
- 2021-11-19 US US18/259,499 patent/US20240327407A1/en active Pending
- 2021-11-19 CN CN202180092869.1A patent/CN116806150A/zh active Pending
- 2021-11-19 DK DK21917385.3T patent/DK4274572T3/da active
- 2021-11-19 FI FIEP21917385.3T patent/FI4274572T3/fi active
- 2021-11-19 HR HRP20260363TT patent/HRP20260363T1/hr unknown
- 2021-11-19 EP EP25184407.2A patent/EP4599849A3/en active Pending
- 2021-11-19 KR KR1020237025750A patent/KR20230128511A/ko active Pending
- 2021-11-19 WO PCT/IB2021/060738 patent/WO2022149010A1/en not_active Ceased
- 2021-11-19 EP EP21917385.3A patent/EP4274572B1/en active Active
- 2021-11-19 PL PL21917385.3T patent/PL4274572T3/pl unknown
- 2021-11-26 TW TW110144219A patent/TW202235078A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN116806150A (zh) | 2023-09-26 |
| EP4599849A3 (en) | 2025-10-22 |
| KR20230128511A (ko) | 2023-09-05 |
| TW202235078A (zh) | 2022-09-16 |
| DK4274572T3 (da) | 2026-03-23 |
| HRP20260363T1 (hr) | 2026-04-24 |
| EP4274572A1 (en) | 2023-11-15 |
| FI4274572T3 (fi) | 2026-03-27 |
| EP4274572A4 (en) | 2025-04-02 |
| EP4274572B1 (en) | 2026-02-18 |
| JP2024502337A (ja) | 2024-01-18 |
| US20240327407A1 (en) | 2024-10-03 |
| PT4274572T (pt) | 2026-03-11 |
| EP4599849A2 (en) | 2025-08-13 |
| WO2022149010A1 (en) | 2022-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE061482T2 (hu) | Szintézismódszer | |
| IL289878A (en) | Tricyclic amides as inhibitors of cd38 | |
| EP3982949A4 (en) | MRSA1 INHIBITORS | |
| ZA202203770B (en) | Pharmaceutical combination of prmt5 inhibitors | |
| IL305751A (en) | SYNTHESIS OF OMECAMTIV MECARBIL | |
| EP4028013A4 (en) | MRSA1 INHIBITORS | |
| IL308476A (en) | Inhibitors of the menin-mil interaction | |
| IL287630A (en) | Solid forms of glyt1 inhibitor | |
| GB202103774D0 (en) | Detectiion of Ransomware | |
| HUE072981T2 (hu) | Azakinolinok mint CD38 gátlók | |
| IL314049A (en) | PARP7 inhibitors | |
| IL276312B1 (en) | Use of Alkoxypyrazoles as nitrification inhibitors | |
| GB201904612D0 (en) | Reaction of glycoladehyde | |
| SG11202008925VA (en) | Inhibitors of micro-rna 22 | |
| IL304159A (en) | A preparation containing bl-8040 | |
| KR102423280B9 (ko) | Sot-mram 면적 최적화 기법 | |
| IL311128A (en) | Synthesis of neurogestate | |
| IL290324A (en) | Preparations containing tropintide | |
| HUE067997T2 (hu) | Szubsztituált 2-tiazolinok mint nitrifikációs inhibitorok | |
| PL4274572T3 (pl) | Nowe inhibitory autotaksyny | |
| IL277869A (en) | Substituted propanamides as nuclease inhibitors | |
| EP3965760A4 (en) | SYNTHESIS OF CRAC CHANNEL INHIBITORS | |
| EP4041735A4 (en) | MYELOPEROXIDASE INHIBITOR PRODRUGS | |
| IL291368A (en) | Inhibits expression of methadherin | |
| GB201903055D0 (en) | Method of oligonucleaotide synthesis |